| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-14 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-11 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-11 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-09 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.24 | 5e-08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.22 | 1e-07 |